Crossmark

Implementation and evaluation of an e-health innovation for personalized care for patients with amyotrophic lateral sclerosis (ALS): protocol for a participatory action research study

Crossref DOI link: https://doi.org/10.1186/s43058-021-00130-z

Published Online: 2021-02-25

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

,

Dontje, M. L. https://orcid.org/0000-0002-0348-9556
Kruitwagen - van Reenen, E.

Visser-Meily, J. M. A.

Beelen, A.
Funding

Funding for this research was provided by:

ZonMw (80-83935-98-025)

Stichting ALS Nederland (2016-51)
License Information

Text and Data Mining valid from 2021-02-25

Version of Record valid from 2021-02-25
More Information

Article History

Received: 10 February 2021

Accepted: 15 February 2021

First Online: 25 February 2021

Ethics approval and consent to participate

: Ethical approval for this study was waived by the Research Ethics Committee of the University Medical Centre Utrecht (20-204/C) and the study is registered in the Netherlands Trial Register (NL8542, 2020-04-15).

: Not applicable.

: All authors declare that they have no competing interests.

Document is current

Any future updates will be listed below